Spironolactone and risk of upper gastrointestinal events: Population based case-control study

British Medical Journal

Volumn 333, Issue 7563, 2006, Pages 330-333

  Verhamme, Katia M C ^a   Mosis, Georgio ^a   Dieleman, Jeanne P ^a   Stricker, Bruno H Ch ^a   Sturkenboom, Miriam C J M ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

SPIRONOLACTONE; ALDOSTERONE ANTAGONIST; DIURETIC AGENT;

ADULT; AGED; ALCOHOLISM; ARTICLE; CONTROLLED STUDY; GASTROINTESTINAL HEMORRHAGE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RISK FACTOR; ULCER; ADOLESCENT; CASE CONTROL STUDY; CHEMICALLY INDUCED DISORDER; DUODENUM ULCER; FEMALE; MALE; MIDDLE AGED; PEPTIC ULCER BLEEDING; STOMACH ULCER;

ADOLESCENT; ADULT; AGED; ALDOSTERONE ANTAGONISTS; CASE-CONTROL STUDIES; DIURETICS; DUODENAL ULCER; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIC ULCER HEMORRHAGE; RISK FACTORS; SPIRONOLACTONE; STOMACH ULCER;

EID: 33747617316     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.38883.479549.2F     Document Type: Article

References (9)

1. Mackay A, Stevenson RD. Gastric ulceration induced by spironolactone. Lancet 1977;1(8009):481.
2. Kremer D, Fraser R, Brown JJ, Lever AF, Davies DL, Robertson JI. Amiloride in primary hyperaldosteronism with chronic peptic ulceration. BMJ 1973;2:216-7.
3. Doll R, Langman MJ, Shawdon HH. Treatment of gastric ulcer with carbenoxolone: antagonistic effect of spironolactone. Gut 1968;9:42-5.
4. Reed PI, Lewis SI, Vincent-Brown A, Holdstock DJ, Gribble RJ, Murgatroyd RE, et al. The influence of amiloride on the therapeutic and metabolic effects of carbenoxolone in patients with gastric ulcer. A double-blind controlled trial. Scand J Gastroenterol Suppl 1980;65:51-7.
5. Slight SH, Chilakamarri VK, Nasr S, Dhalla AK, Ramires FJ, Sun Y, et al. Inhibition of tissue repair by spironolactone: role of mineralocorticoids in fibrous tissue formation. Mol Cell Biochem 1998;189:47-54.
6. Lijnen P, Petrov V. Induction of cardiac fibrosis by aldosterone. J Mol Cell Cardiol 2000;32:865-79.
7. Kato K, Sasano H, Ohara S, Sekine H, Mochizuki S, Mune T, et al. Coexpression of mineralocorticoid receptors and 11beta-hydroxysteroid dehydrogenase 2 in human gastric mucosa. J Clin Endocrinol Metab 1999;84:2568-73.
8. Weil J, Langman MJ, Wainwright P, Lawson DH, Rawlins M, Logan RF, et al. Peptic ulcer bleeding: accessory risk factors and interactions with non-steroidal anti-inflammatory drugs. Gut 2000;46:27-31.
9. Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, et al. Rates of hyperkalemia after publication of the randomized aldactone evaluation study. N Engl J Med 2004;351:543-51.